1-3 of 3
Aradhana Awasthi, Ph.D
Close
Sort by
Journal Articles

Obinutuzumab (GA101) Significantly Improves Survival In CD20 Positive Pre-B Cell Lymphoblastic Leukemia (pre-B-ALL) Xenograft Models Compared To Rituximab (RTX): Potential Targeted Therapy In Patients With High Risk Pre-B-ALL

Aradhana Awasthi, Ph.D, Janet Ayello, MS, MT(ASCP), Carmella van de Ven, MA, Stefan Hovy, Mitchell S. Cairo, MD
Journal: Blood
Blood (2013) 122 (21): 3068.
https://doi.org/10.1182/blood.V122.21.3068.3068
Published: 2013
Journal Articles

The Acquirement Of Rituximab Resistance Is Associated With De-Regulation Of The PI3K/Akt/mTOR Signaling Pathway Leading To Chemotherapy Resistance In Burkitt Lymphoma Pre-Clinical Models

Sarah Frys, BSc, Andrew Skomra, Natalie M Czuczman, BSc, Cory Mavis, BSc, MSc, Delphine C.M. Rolland, PharmD, PhD, Megan Lim, MD, PhD, Aradhana Awasthi, Ph.D, Mitchell S. Cairo, MD, Myron S. Czuczman, MD, Francisco J. Hernandez-Ilizaliturri, MD, Matthew J. Barth, MD
Journal: Blood
Blood (2013) 122 (21): 5144.
https://doi.org/10.1182/blood.V122.21.5144.5144
Published: 2013
Journal Articles

Global Phosphoproteomics Analysis Of Burkitt Lymphoma (BL) Demonstrates Abnormal Protein Phosphorylation In BCR, Spliceosome, mTOR and Chemokine Signaling Pathways In Rituximab Induced Resistant BL

Aradhana Awasthi, Ph.D, Delphine Rolland, Ph.D, Matthew J. Barth, MD, Janet Ayello, MS, MT(ASCP), Carmella van de Ven, MA, Myron S. Czuczman, MD, Kojo S.J. Elenitoba-Johnson, MD, Megan Lim, MD, PhD, Mitchell S. Cairo, MD
Journal: Blood
Blood (2013) 122 (21): 928.
https://doi.org/10.1182/blood.V122.21.928.928
Published: 2013